PharmaTech Integrates 2022
, 21 September 2023, GLASGOW
PHARMATECH INTEGRATES 2022 AGENDA
KEYNOTES, FIRESIDE CHATS AND PANEL DISCUSSIONS
In addition, there will be the opportunity to attend a tour of the Medicines Manufacturing Innovation Centre on Wednesday 21 September from 13:00 – 16:00. You can be one of the first to see this brand new facility and you’ll also be able to network and hear from the Medicines Manufacturing Innovation Centre and wider CPI teams who will be available to discuss each of the Grand Challenges. Refreshments will be provided.
On the day of the event CMAC, who are based within the Technology and Innovation Centre, will also be offering a tour of their world-class facilities. This will provide you the opportunity to meet with key researchers and to see the innovative technologies they are developing, including the robotics they have integrated into the Digital CMC and data-factory stream.
MAKING AND TAKING
Focusing on advances in manufacturing, formulation and drug delivery technologies
FIT FOR THE FUTURE
Focusing on new therapies and the technology developments required for them to realise their full potential
DIGITAL OUTCOMES
Defining and implementing the right digital and data strategies for Pharma’s future
Registration and Networking
08:00 – 09:00
Registration and Networking
Welcome & Opening Remarks
09:00 – 09:10
Welcome & Opening Remarks
DAVE TUDOR | Managing Director | MMIC, Biologics & Quality
Fireside Chat
09:10 – 09:30
Fireside Chat
MARTIN MEESON | Chief Executive Officer | FUJIFILM Diosynth Biotechnologies
Fireside Chat
09:30 – 09:50
Fireside Chat with
MAUREEN WEDDERBURN | Non Executive Chair | Medicines Manufacturing Innovation Centre
STEVEN BAGSHAW CBE | Bio industrial Specialist and Non-Executive Director | CPI
Morning refreshment
09:50 – 10:30
Morning Refreshment & Networking
Session 1
10:30 – 11:20
Pro-Active Ingredients
Building on the advances in process intensification and continuous manufacturing to further enhance the efficiency and quality of active ingredients manufacturing.
Gene Genie
Identifying the next steps to drive forward the potential of oligonucleotides, DNA and RNA based therapeutics
Making Predictions
Using AI, VR, simulations and digital twins to support pharma from drug development, process scale-up, facility design and operator training
Session 2
11:30 – 12:20
Implications of Point of Care and Distributed Manufacture
As medicines become more stratified and manufacturing runs become smaller, how should the manufacturing network change to keep up?
ADC… it’s as easy as 1,2,3…4?
The accelerating growth in Antibody Drug Conjugate (ADC) development and commercialisation provides an exciting outlook for targeted therapies
Rise of robotics
How can robotics and automated systems optimise the development of medicines to lower the costs, reduce the environmental impact and increase the speed to market?
Lunch Break
12:20 – 13:30
Lunch & Networking
Session 3
13:30 – 14:20
Free Form Thinking
Applying the rapidly advancing knowledge and technologies for the control of physical form and formulation to enhance product application, performance and safety
Please join Track 1 or 3
Silicon rally
Speeding the adoption of real time data collection and systems integration to enhance the productivity, quality, reproducibility and compliance of pharma production processes.
Session 4
14:30 – 15:20
Special Delivery
How finished dose form technologies are advancing to deliver more efficient products, better supply chains and improved patient outcomes
Hard Cell
Addressing the considerable challenges for improving the production of advanced cell and gene therapies.
Digital, Data and the Pharma Supply Chain
Digital and Data based solutions for more effective and efficient pharm supply chains and logistics, which enhance patient access and reduce healthcare costs
Drinks reception
15:20 – 16:30
Drinks reception & Networking
Sign up for life science integrates news
Get the latest news and updates by signing up today.
By signing up to the life science integrates newsletter, you have read and agree to our Privacy Policy, including our Cookie use.
PharmaTech Integrates 2022
, 21 September 2023, GLASGOW
PHARMATECH INTEGRATES 2022 AGENDA
KEYNOTES, FIRESIDE CHATS AND PANEL DISCUSSIONS
In addition, there will be the opportunity to attend a tour of the Medicines Manufacturing Innovation Centre on Wednesday 21 September from 13:00 – 16:00. You can be one of the first to see this brand new facility and you’ll also be able to network and hear from the Medicines Manufacturing Innovation Centre and wider CPI teams who will be available to discuss each of the Grand Challenges. Refreshments will be provided.
On the day of the event CMAC, who are based within the Technology and Innovation Centre, will also be offering a tour of their world-class facilities. This will provide you the opportunity to meet with key researchers and to see the innovative technologies they are developing, including the robotics they have integrated into the Digital CMC and data-factory stream.
Registration and Networking
08:00 – 09:00
Welcome & Opening Remarks
09:00 – 09:10
DAVE TUDOR | Managing Director | MMIC, Biologics & Quality
Fireside Chat
09:10 – 09:30
MARTIN MEESON | Chief Executive Officer | FUJIFILM Diosynth Biotechnologies
Fireside Chat
09:30 – 09:50
MAUREEN WEDDERBURN | Non Executive Chair | Medicines Manufacturing Innovation Centre
STEVEN BAGSHAW CBE | Bio industrial Specialist and Non-Executive Director | CPI
Morning Refreshment and Networking
09:50 – 10:30
MAKING AND TAKING
Focusing on advances in manufacturing, formulation and drug delivery technologies
Session 1
10:30 – 11:20
Pro-Active Ingredients
Building on the advances in process intensification and continuous manufacturing to further enhance the efficiency and quality of active ingredients manufacturing.
Session 2
11:30 – 12:20
Implications of Point of Care and Distributed Manufacture
As medicines become more stratified and manufacturing runs become smaller, how should the manufacturing network change to keep up?
What structural challenges do these changes present and how can we use manufacturing innovation and digital tools, along with updated regulatory strategies, to grasp the opportunities?
Lunch and Networking
12:20 – 13:30
Session 3
13:30 – 14:20
Free Form Thinking
Applying the rapidly advancing knowledge and technologies for the control of physical form and formulation to enhance product application, performance and safety
Session 4
14:30 – 15:20
Special Delivery
How finished dose form technologies are advancing to deliver more efficient products, better supply chains and improved patient outcomes
FIT FOR THE FUTURE
Focusing on new therapies and the technological advances in manufacturing required to support them
Session 1
10:30 – 11:20
Gene Genie
Identifying the next steps to drive forward the potential of oligonucleotides, DNA and RNA based therapeutics
Session 2
11:30 – 12:20
ADC… it’s as easy as 1,2,3…4?
The accelerating growth in Antibody Drug Conjugate (ADC) development and commercialisation provides an exciting outlook for targeted therapies – but with four complex, disparate, components to bring together (antibody, toxin-linker, bioconjugation, sterile fill-finish), what does the current partnership model look like, and how must CDMOs evolve to meet future development and manufacturing requirements in this space?
Lunch & Networking
12:20 – 13:30
Session 3
13:30 – 14:20
Please join Track 1 or 3
Session 4
14:30 – 15:20
Hard Cell
Addressing the considerable challenges for improving the production of advanced cell and gene therapies.
DIGITAL OUTCOMES
Defining and implementing the right digital and data strategies for Pharma’s future
Session 1
10:30 – 11:20
Making Predictions
Using AI, VR, simulations and digital twins to support pharma from drug development, process scale-up, facility design and operator training
Session 2
11:30 – 12:20
Rise of robotics
The 4th industrial revolution has seen the development and uptake of advanced robotics and automated systems to carry out tasks that can be classed as Dangerous, Dirty, Dull, Dear or Difficult, or that can require or generate Data, often in sectors with similar degrees of regulation. As the pharma industry seeks to reduce the time to market for new therapies in a manner that lowers cost and reduces environmental impact, this session will explore the role for increased adoption of these technologies to help achieve these objectives.
Lunch & Networking
12:20 – 13:30
Session 3
13:30 – 14:20
Silicon rally
Speeding the adoption of real time data collection and systems integration to enhance the productivity, quality, reproducibility and compliance of pharma production processes.
Session 4
14:30 – 15:20
Digital, Data and the Pharma Supply Chain
Digital and Data based solutions for more effective and efficient pharm supply chains and logistics, which enhance patient access and reduce healthcare costs
Drinks Reception
15:20 – 16:30
Sign up for life science integrates news
Get the latest news and updates by signing up today.
By signing up to the life science integrates newsletter, you have read and agree to our Privacy Policy, including our Cookie use.